{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T08:16:18Z","timestamp":1788336978679,"version":"build-2803163510"},"reference-count":56,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pediatric Clinics of North America"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.pcl.2021.07.006","type":"journal-article","created":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T21:26:30Z","timestamp":1635801990000},"page":"1293-1307","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Pediatric Autoimmune Liver Diseases"],"prefix":"10.1016","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9524-3288","authenticated-orcid":false,"given":"Sarah","family":"Kemme","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cara L.","family":"Mack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.pcl.2021.07.006_bib1","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.1097\/MPG.0000000000002122","article-title":"Incidence and clinical features of autoimmune hepatitis in the province of Santa Fe (Argentina)","volume":"67","author":"Costaguta","year":"2018","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"4","key":"10.1016\/j.pcl.2021.07.006_bib2","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/hep.26454","article-title":"Primary sclerosing cholangitis, autoimmune hepatitis, and overlap in Utah children: epidemiology and natural history","volume":"58","author":"Deneau","year":"2013","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.pcl.2021.07.006_bib3","doi-asserted-by":"crossref","first-page":"e1237","DOI":"10.1542\/peds.2015-0578","article-title":"Incidence and characteristics of autoimmune hepatitis","volume":"136","author":"Jimenez-Rivera","year":"2015","journal-title":"Pediatrics"},{"issue":"9","key":"10.1016\/j.pcl.2021.07.006_bib4","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1155\/2007\/757906","article-title":"Retrospective review of pediatric and adult autoimmune hepatitis in two quaternary care centres in British Columbia: increased prevalence seen in British Columbia's First Nations community","volume":"21","author":"Chung","year":"2007","journal-title":"Can J Gastroenterol"},{"issue":"9","key":"10.1016\/j.pcl.2021.07.006_bib5","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1007\/s10620-017-4675-y","article-title":"Global disparities and their implications in the occurrence and outcome of autoimmune hepatitis","volume":"62","author":"Czaja","year":"2017","journal-title":"Dig Dis Sci"},{"issue":"3","key":"10.1016\/j.pcl.2021.07.006_bib6","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/hep.510250308","article-title":"Autoimmune hepatitis in childhood: a 20-year experience","volume":"25","author":"Gregorio","year":"1997","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.pcl.2021.07.006_bib7","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.dld.2010.01.002","article-title":"Autoimmune hepatitis in children--impact of cirrhosis at presentation on natural history and long-term outcome","volume":"42","author":"Radhakrishnan","year":"2010","journal-title":"Dig Liver Dis"},{"issue":"5","key":"10.1016\/j.pcl.2021.07.006_bib8","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/liv.14081","article-title":"Racial disparities in presentation and outcomes of paediatric autoimmune hepatitis","volume":"39","author":"Palle","year":"2019","journal-title":"Liver Int"},{"issue":"4","key":"10.1016\/j.pcl.2021.07.006_bib9","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.autrev.2010.09.024","article-title":"Autoimmune hepatitis, HLA and extended haplotypes","volume":"10","author":"Oliveira","year":"2011","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1016\/j.pcl.2021.07.006_bib10","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1053\/jhep.2001.22131","article-title":"Autoimmune hepatitis\/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study","volume":"33","author":"Gregorio","year":"2001","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.pcl.2021.07.006_bib11","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/MPG.0000000000000245","article-title":"Autoantibody and human leukocyte antigen profiles in children with autoimmune liver disease and their first-degree relatives","volume":"58","author":"Wang","year":"2014","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"1","key":"10.1016\/j.pcl.2021.07.006_bib12","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/MPG.0000000000001125","article-title":"Clinical characteristics and prognosis in children and adolescents with autoimmune hepatitis and overlap syndrome","volume":"63","author":"Rodrigues","year":"2016","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"1","key":"10.1016\/j.pcl.2021.07.006_bib13","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/MPG.0000000000001563","article-title":"Outcomes in pediatric autoimmune hepatitis and significance of azathioprine metabolites","volume":"65","author":"Sheiko","year":"2017","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"4","key":"10.1016\/j.pcl.2021.07.006_bib14","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/MPG.0b013e3182602b20","article-title":"Autoimmune hepatitis in children in Eastern Denmark","volume":"55","author":"Vitfell-Pedersen","year":"2012","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"10","key":"10.1016\/j.pcl.2021.07.006_bib15","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1097\/MEG.0000000000000424","article-title":"Autoimmune liver disease and concomitant extrahepatic autoimmune disease","volume":"27","author":"Muratori","year":"2015","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.pcl.2021.07.006_bib16","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/hep.31065","article-title":"Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American Association for the Study of Liver Diseases","volume":"72","author":"Mack","year":"2020","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.pcl.2021.07.006_bib17","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/modpathol.2016.267","article-title":"Autoimmune hepatitis: review of histologic features included in the simplified criteria proposed by the international autoimmune hepatitis group and proposal for new histologic criteria","volume":"30","author":"Balitzer","year":"2017","journal-title":"Mod Pathol"},{"issue":"8","key":"10.1016\/j.pcl.2021.07.006_bib18","first-page":"1206","article-title":"The validity and importance of subtypes in autoimmune hepatitis: a point of view","volume":"90","author":"Czaja","year":"1995","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.pcl.2021.07.006_bib19","first-page":"376","article-title":"Autoimmune hepatitis associated with anti-actin antibodies in children and adolescents","volume":"17","author":"Maggiore","year":"1993","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"5","key":"10.1016\/j.pcl.2021.07.006_bib20","first-page":"417","article-title":"Presumed cryptogenic liver disease in Germany: high prevalence of autoantibody-negative autoimmune hepatitis, low prevalence of NASH, no evidence for occult viral etiology","volume":"47","author":"Heringlake","year":"2009","journal-title":"Z\u00a0Gastroenterol"},{"issue":"1","key":"10.1016\/j.pcl.2021.07.006_bib21","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.cgh.2008.08.043","article-title":"Serologic markers do not predict histologic severity or response to treatment in patients with autoimmune hepatitis","volume":"7","author":"Mehendiratta","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.pcl.2021.07.006_bib22","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.dld.2016.03.015","article-title":"Seronegative autoimmune hepatitis in children: spectrum of disorders","volume":"48","author":"Maggiore","year":"2016","journal-title":"Dig Liver Dis"},{"issue":"2","key":"10.1016\/j.pcl.2021.07.006_bib23","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0022-3476(05)82892-6","article-title":"Autoimmune hepatitis with initial presentation as acute hepatic failure in young children","volume":"116","author":"Maggiore","year":"1990","journal-title":"J\u00a0Pediatr"},{"issue":"2","key":"10.1016\/j.pcl.2021.07.006_bib24","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/MPG.0000000000002940","article-title":"Outcomes of severe seronegative hepatitis-associated aplastic anemia: a pediatric case series","volume":"72","author":"Kemme","year":"2021","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"3","key":"10.1016\/j.pcl.2021.07.006_bib25","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0049-0172(98)80035-8","article-title":"Coexistent minocycline-induced systemic lupus erythematosus and autoimmune hepatitis","volume":"28","author":"Angulo","year":"1998","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.pcl.2021.07.006_bib26","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0049-0172(99)80004-3","article-title":"Minocycline-induced autoimmune syndromes: an overview","volume":"28","author":"Elkayam","year":"1999","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.pcl.2021.07.006_bib27","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1002\/hep.23588","article-title":"Drug-induced autoimmune hepatitis: clinical characteristics and prognosis","volume":"51","author":"Bjornsson","year":"2010","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.pcl.2021.07.006_bib28","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1001\/archpedi.152.11.1132","article-title":"Minocycline-related autoimmune hepatitis: case series and literature review","volume":"152","author":"Teitelbaum","year":"1998","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.pcl.2021.07.006_bib29","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.coi.2016.07.003","article-title":"AIRE-mutations and autoimmune disease","volume":"43","author":"Bruserud","year":"2016","journal-title":"Curr Opin Immunol"},{"issue":"3","key":"10.1016\/j.pcl.2021.07.006_bib30","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1055\/s-0029-1233535","article-title":"The autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy or autoimmune polyglandular syndrome type 1","volume":"29","author":"Lankisch","year":"2009","journal-title":"Semin Liver Dis"},{"issue":"6","key":"10.1016\/j.pcl.2021.07.006_bib31","doi-asserted-by":"crossref","first-page":"102526","DOI":"10.1016\/j.autrev.2020.102526","article-title":"Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome: a systematic review","volume":"19","author":"Park","year":"2020","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1016\/j.pcl.2021.07.006_bib32","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/PAS.0000000000001452","article-title":"Spectrum of hepatic manifestations of common variable immunodeficiency","volume":"44","author":"Crotty","year":"2020","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.pcl.2021.07.006_bib33","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1007\/s10875-013-9873-6","article-title":"Nodular regenerative hyperplasia in common variable immunodeficiency","volume":"33","author":"Fuss","year":"2013","journal-title":"J\u00a0Clin Immunol"},{"issue":"6","key":"10.1016\/j.pcl.2021.07.006_bib34","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/01.md.0000100046.06009.b0","article-title":"The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients","volume":"82","author":"Winkelstein","year":"2003","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"10.1016\/j.pcl.2021.07.006_bib35","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.jhepr.2019.10.005","article-title":"Efficacy of rituximab in difficult-to-manage autoimmune hepatitis: results from the International Autoimmune Hepatitis Group","volume":"1","author":"Than","year":"2019","journal-title":"JHEP Rep"},{"issue":"3","key":"10.1016\/j.pcl.2021.07.006_bib36","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jhep.2014.10.018","article-title":"Patient selection based on treatment duration and liver biochemistry increases success rates after treatment withdrawal in autoimmune hepatitis","volume":"62","author":"Hartl","year":"2015","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.pcl.2021.07.006_bib37","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"European Association for the Study of the L. EASL clinical practice guidelines: autoimmune hepatitis","volume":"63","year":"2015","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.pcl.2021.07.006_bib38","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/MPG.0b013e3181bf0ef7","article-title":"Childhood autoimmune liver disease: indications and outcome of liver transplantation","volume":"50","author":"Chai","year":"2010","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"8","key":"10.1016\/j.pcl.2021.07.006_bib39","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1080\/0891693021000056721","article-title":"Organ and non-organ specific autoantibody titres and IgG levels as markers of disease activity: a longitudinal study in childhood autoimmune liver disease","volume":"35","author":"Gregorio","year":"2002","journal-title":"Autoimmunity"},{"issue":"4","key":"10.1016\/j.pcl.2021.07.006_bib40","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/lt.22244","article-title":"Outcomes in children who underwent transplantation for autoimmune hepatitis","volume":"17","author":"Martin","year":"2011","journal-title":"Liver Transpl"},{"issue":"4","key":"10.1016\/j.pcl.2021.07.006_bib41","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1097\/MPG.0000000000001438","article-title":"Liver transplantation for children with primary sclerosing cholangitis and autoimmune hepatitis: UNOS database analysis","volume":"64","author":"Jossen","year":"2017","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.pcl.2021.07.006_bib42","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1471-230X-11-83","article-title":"The prevalence, incidence and natural history of primary sclerosing cholangitis in an ethnically diverse population","volume":"11","author":"Toy","year":"2011","journal-title":"BMC Gastroenterol"},{"issue":"9904","key":"10.1016\/j.pcl.2021.07.006_bib43","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/S0140-6736(13)60096-3","article-title":"Primary sclerosing cholangitis","volume":"382","author":"Hirschfield","year":"2013","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.pcl.2021.07.006_bib44","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.jhep.2017.07.022","article-title":"Primary sclerosing cholangitis - a comprehensive review","volume":"67","author":"Karlsen","year":"2017","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.pcl.2021.07.006_bib45","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3748\/wjg.v25.i6.659","article-title":"Cancer risk in primary sclerosing cholangitis: epidemiology, prevention, and surveillance strategies","volume":"25","author":"Fung","year":"2019","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.pcl.2021.07.006_bib46","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/hep.29204","article-title":"The natural history of primary sclerosing cholangitis in 781 children: a multicenter, international collaboration","volume":"66","author":"Deneau","year":"2017","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.pcl.2021.07.006_bib47","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1111\/j.1572-0241.2007.01103.x","article-title":"The burden of large and small duct primary sclerosing cholangitis in adults and children: a population-based analysis","volume":"102","author":"Kaplan","year":"2007","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.pcl.2021.07.006_bib48","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/MPG.0000000000001789","article-title":"Lack of correlation of liver tests with fibrosis stage at diagnosis in pediatric primary sclerosing cholangitis","volume":"66","author":"Cotter","year":"2018","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"Suppl 2","key":"10.1016\/j.pcl.2021.07.006_bib49","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000440708","article-title":"Paediatric autoimmune liver disease","volume":"33","author":"Liberal","year":"2015","journal-title":"Dig Dis"},{"issue":"5","key":"10.1016\/j.pcl.2021.07.006_bib50","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/cld.672","article-title":"Primary sclerosing cholangitis: unique aspects of disease in children","volume":"10","author":"Cotter","year":"2017","journal-title":"Clin Liver Dis (Hoboken)"},{"issue":"1","key":"10.1016\/j.pcl.2021.07.006_bib51","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1053\/jhep.2003.50289","article-title":"Primary sclerosing cholangitis in children: a long-term follow-up study","volume":"38","author":"Feldstein","year":"2003","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.pcl.2021.07.006_bib52","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.cgh.2008.10.019","article-title":"A\u00a0retrospective single-center review of primary sclerosing cholangitis in children","volume":"7","author":"Miloh","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.pcl.2021.07.006_bib53","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11894-018-0620-2","article-title":"The IBD and PSC phenotypes of PSC-IBD","volume":"20","author":"Ricciuto","year":"2018","journal-title":"Curr Gastroenterol Rep"},{"issue":"11","key":"10.1016\/j.pcl.2021.07.006_bib54","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1002\/hep4.1251","article-title":"Gamma glutamyltransferase reduction is associated with favorable outcomes in pediatric primary sclerosing cholangitis","volume":"2","author":"Deneau","year":"2018","journal-title":"Hepatol Commun"},{"issue":"3","key":"10.1016\/j.pcl.2021.07.006_bib55","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/hep.31393","article-title":"The Sclerosing Cholangitis Outcomes in Pediatrics (SCOPE) index: a prognostic tool for children","volume":"73","author":"Deneau","year":"2021","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.pcl.2021.07.006_bib56","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4254\/wjh.v11.i1.19","article-title":"Treatment of primary sclerosing cholangitis in children","volume":"11","author":"Laborda","year":"2019","journal-title":"World J Hepatol"}],"container-title":["Pediatric Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031395521001139?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031395521001139?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T17:25:23Z","timestamp":1758475523000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031395521001139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":56,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S0031395521001139"],"URL":"https:\/\/doi.org\/10.1016\/j.pcl.2021.07.006","relation":{},"ISSN":["0031-3955"],"issn-type":[{"value":"0031-3955","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pediatric Autoimmune Liver Diseases","name":"articletitle","label":"Article Title"},{"value":"Pediatric Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcl.2021.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}